HomeMillar Inc.Millar Earns CE Mark Expansion for Intra-compartmental and Airway Pressure Measurements Using the Mikro-Cath™ Pressure Catheter

Millar Earns CE Mark Expansion for Intra-compartmental and Airway Pressure Measurements Using the Mikro-Cath™ Pressure Catheter

Millar, Inc., medical device manufacturer and OEM solutions partner, is pleased to announce the expansion of the Mikro-Cath Pressure Catheter CE mark to include airway and intra-compartmental pressure measurements, providing European physicians and clinical researchers with access to high-fidelity pressure data that is reliable and unaffected by patient movement or position. The Mikro-Cath had been previously approved for cardiovascular pressure measurements in Europe and received FDA clearance in March 2017 for the expanded indications.

Originally designed as a cardiovascular medical device, it was quickly determined the Mikro-Cath could add value to other clinical applications. The new expansion will allow leading physicians in Europe to seek improvements in respiratory care as well as deliver a continuous monitoring technique for measuring compartment pressure and accurately diagnosing acute compartment syndrome as soon as it’s suspected. The Mikro-Cath can also be readily integrated in more critical care programs involving trauma patients undergoing ventilation treatment. The increased level of continuous data accuracy for both respiratory and compartment pressure applications may also support faster decision making with improved data.

“This has been a long awaited approval and we look forward to working with physicians that have been eager to utilize the Mikro-Cath for these applications. We anticipate that this will open an opportunity for an improvement in patient care, specifically in the respiratory market,” reports Matthew Davis, Director of International Sales and Business Development.

Millar also received ISO 13485:2016 certification of its quality management system following completion of an audit by British Standards Institute (BSI), the international governing body for quality medical device manufacturing. This certification demonstrates the company’s focus on quality and demonstrates its ability to provide medical devices that consistently meet both customer and applicable regulatory requirements.

For nearly 50 years, Millar has manufactured MEMS sensor-enabled catheters that deliver the most reliable measurement of physiologic pressures and have been used to advance medical research and device development in cardiovascular, urodynamic, neurosurgical care and orthopedic applications.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy